Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
---|
07/29/2008 | US7405209 Protease inhibitors |
07/29/2008 | US7405201 Antibacterial macrocycles |
07/29/2008 | US7405200 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
07/29/2008 | US7405194 Therapeutic agents and methods of use thereof for the treatment of melanoma |
07/29/2008 | US7404948 Peptidic conjugates for alopecia prevention and treatment |
07/29/2008 | CA2405486C Method for synthesis of perindopril and its pharmaceutically acceptable salts |
07/29/2008 | CA2203033C Compounds and compositions for delivering active agents |
07/24/2008 | WO2008070141A3 Compositions for delivery of therapeutic agents |
07/24/2008 | WO2008064465B1 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl- d-tryptophan |
07/24/2008 | WO2008033328A3 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders |
07/24/2008 | US20080177036 Selective Linear Peptides with Melanocortin-4 Receptor (MC4-R) Agonist Activity |
07/24/2008 | US20080177034 Taspase1 and Methods of Use |
07/24/2008 | US20080177033 Self-Assembly of Peptide-Amphiphile Nanofibers under Physiological Conditions |
07/24/2008 | US20080177029 Halogenation and sulfonation of a 4-hydroxy-quinolone, ring closing metathesis with 2nd generation Hoveyda's catalyst of 2-(2-(cyclopropyl-2-propenyl)aminocarbonyl)-4-hydroxy-5-alkenoyl) pyrrolidine, etherification with the quinolone; one pot process; Hepatitis C viricides |
07/24/2008 | US20080176807 Facially amphiphilic polymers and oligomers and uses thereof |
07/24/2008 | US20080176806 Therapeutic uses of tri-, tetra-, penta-, and polypeptides |
07/24/2008 | US20080176792 Vegfr-1 targeting peptides |
07/24/2008 | US20080176243 Designing vector system comprising regulatory sequences which utilize human chorionic gonadotropin and/or nuclear factor kappaB as modulators of genic expression |
07/24/2008 | CA2675753A1 Substance p and analogs thereof as an immunogenic composition adjuvant |
07/24/2008 | CA2661651A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
07/23/2008 | EP1947109A2 Biologically active peptides |
07/23/2008 | EP1946110A1 Kokumi-imparting agent |
07/23/2008 | EP1945201A2 Calcium receptor activator |
07/23/2008 | CN101228182A Antibakterielle amid-makrozyklen v |
07/23/2008 | CN101228181A HCV NS3 protease inhibitors |
07/23/2008 | CN101228180A Tripeptides as hepatitis C virus inhibitors |
07/23/2008 | CN101228179A A process for the preparation of perindopril erbumine |
07/23/2008 | CN101228169A Macrocyclic inhibitors of hepatitis c virus |
07/23/2008 | CN101225094A Anthraquinones tetracyclic compound having anticancer activity |
07/23/2008 | CN100405062C Therapeutic and diagnostic uses of antibody specificity profiles |
07/23/2008 | CN100404548C Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
07/22/2008 | US7402663 Obesity, antidiabetic agents |
07/22/2008 | US7402653 Biologically active peptides |
07/22/2008 | US7402600 Nitroderivatives of cardiovascular agents |
07/22/2008 | US7402586 3-Benzylsulfonylamino-6-methyl-1-[(3-guanidinooxypropyl)aminocarbonylmethyl]-2-pyridinone trifluoroacetate; anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage |
07/22/2008 | US7402561 Of a human papilloma virus-infected cell; topical administration of an oligopeptide halomethyl ketone inhibitor of a chymotrypsin or chymotrypsin-like protease to decrease the amount of viral DNA in the cell; preferred inhibitor is ala-ala-pro-phe chloromethyl ketone |
07/22/2008 | US7402556 Prodrugs activated by plasmin and their use in cancer chemotherapy |
07/22/2008 | US7402322 Human chorionic gonadotrophin, obtained form urine of pregnant humans, used for prophylaxis of allergies, autoimmune disease, graft versus host disease or as antiinflammatory agents; immunotherapy |
07/17/2008 | WO2008086161A1 Macrocyclic hepatitis c protease inhibitors |
07/17/2008 | WO2008085608A1 Compounds and compositions as channel activating protease inhibitors |
07/17/2008 | WO2008083678A2 Pharmaceutically active compounds |
07/17/2008 | US20080171849 Deprotecting peptide from allyl-type protecting groups by palladium catalysis in presence of allyl acceptor; lactamization; solid phase synthesis |
07/17/2008 | US20080171698 A tripeptide mimetic produced by solid phase synthesis on a modified polystrene resin; ACE inhibitors with prolonged activity, improved bioavailability and side effect reduction |
07/17/2008 | US20080171357 Using escherichia as bioreactor for production of empedobacter or sphingobacterium peptide sequences for use in pharmaceutical and foods |
07/17/2008 | DE102007002386A1 Pharmazeutisch wirksame Verbindungen Pharmaceutically active compounds |
07/17/2008 | CA2679563A1 Macrocyclic hepatitis c protease inhibitors |
07/17/2008 | CA2675029A1 Pharmaceutically active compounds |
07/17/2008 | CA2673803A1 Compounds and compositions as channel activating protease inhibitors |
07/16/2008 | EP1944610A1 Engineering affinity ligands for macromolecules |
07/16/2008 | EP1943267A1 A process for the preparation of perindopril erbumine |
07/16/2008 | CN101223445A Biomarkers for breast cancer |
07/16/2008 | CN101223187A New peptides useful as dual caspase-2/-6 inhibitors and their biological applications |
07/16/2008 | CN101220338A Glutathione produced bacterial strain and construction method thereof |
07/16/2008 | CN100402549C Bridged bicyclic serine protease inhibitors |
07/16/2008 | CN100402089C Angiotensin-converting enzyme inhibitory peptides |
07/15/2008 | US7399749 For therapy and prophylaxis of disorders associated with the HCV protease |
07/15/2008 | US7399747 Peptides carrying substances across the blood brain barrier |
07/15/2008 | US7399630 Cell culture vessel having a polymer surface, a cell adhesion resistant material (CAR) bonded to the polymer (e.g., hyaluronic acid), and one or more peptides covalently bound to the CAR material that promote adherence of cells that do not adhere to the CAR layer in the absence of the peptides |
07/15/2008 | US7399468 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
07/15/2008 | CA2315258C Neuroprotective agents |
07/15/2008 | CA2302524C Stable radioiodine conjugates and methods for their synthesis |
07/15/2008 | CA2274149C Peptides and compounds that bind to a receptor |
07/15/2008 | CA2144473C Pna synthesis using a base-labile amino protecting group |
07/14/2008 | CA2677697A1 Pyrimidine substituted macrocyclic hcv inhibitors |
07/10/2008 | WO2008083288A2 Purifiction of romidepsin |
07/10/2008 | WO2008080845A1 Methods for the synthesis of cyclic peptides |
07/10/2008 | WO2008058679A3 Novel amides acting on the adenosine receptors |
07/10/2008 | WO2007133865A3 Hcv/hiv inhibitors an their uses |
07/10/2008 | WO2007117419A3 Methods and compositions relating to post-prolyl cleaving enzyme inhibitors |
07/10/2008 | CA2674309A1 Preparation of romidepsin |
07/10/2008 | CA2673229A1 Methods for the synthesis of cyclic peptides |
07/09/2008 | EP1940470A2 Antibody-drug conjugates and methods of use |
07/09/2008 | EP1590666B1 Compositions and methods for enhancing apoptosis |
07/09/2008 | EP1338604B9 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing said trimeres |
07/09/2008 | CN101215544A Inflammation-inhibiting compounds |
07/09/2008 | CN101214380A Method and carrier complexes for delivering molecules to cells |
07/08/2008 | US7396906 Pro4399 Polypeptides |
07/08/2008 | US7396859 Perturbed membrane-binding compounds |
07/08/2008 | US7396846 Growth hormone secretagogues |
07/08/2008 | US7396814 Metallopeptide compositions for treatment of sexual dysfunction |
07/08/2008 | US7396812 Administering muramyl tripeptide or a derivative to enhance immune response; particularly for treating gramnegative bacterial infections |
07/08/2008 | US7396665 Produced from Chromobacterium cultures; depsipeptides; immunosuppressants; for treatment of graft-versus-host disease |
07/08/2008 | CA2372377C A novel inhibitor of beta amyloid cleavage enzyme |
07/08/2008 | CA2250712C Chimeric isoprenoid synthases and uses thereof |
07/03/2008 | WO2008077194A1 Receptor agonists |
07/03/2008 | WO2008060927A3 Hepatitis c virus inhibitors |
07/03/2008 | WO2008060927A2 Hepatitis c virus inhibitors |
07/03/2008 | WO2008027162A3 129xe biosensors and their use |
07/03/2008 | WO2008010930A3 Hiv-1 peptides, nucleic acids, and compositions, and uses thereof |
07/03/2008 | WO2007147165A3 Human cancer stem cell culture compositions comprising erbb2 variants and methods of use thereof |
07/03/2008 | US20080160501 Plasma protein-binding ligands |
07/02/2008 | EP1939297A1 Alzheimer's disease secretase |
07/02/2008 | EP1939213A1 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
07/02/2008 | EP1938832A1 Angiotensin-converting enzyme inhibitory peptides |
07/02/2008 | EP1937708A1 Asymmetric synthesis of peptides |
07/02/2008 | EP1937634A1 Cathepsin cysteine protease inhibitors |
07/02/2008 | EP1756142B1 Pseudopeptides growth hormone secretagogues |
07/02/2008 | EP1633702B1 Protease inhibitors |
07/02/2008 | EP1451181B1 Dimeric compounds and their use as anti-viral agents |
07/02/2008 | CN100398661C Casein hydrolyzate, process for producing the same and use thereof |